PMGC Holdings Inc. is projected to decline to $0.8653 by 2027, a -5% move from its current price of $0.912. ELAB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.8693 | $0.9121 | $0.957 | +0.01% |
| Aug 6 | $0.8522 | $0.9122 | $0.9764 | +0.02% |
| Aug 7 | $0.8394 | $0.9123 | $0.9915 | +0.03% |
| Aug 8 | $0.8287 | $0.9124 | $1.00 | +0.04% |
| Aug 9 | $0.8195 | $0.9125 | $1.02 | +0.05% |
| Aug 10 | $0.8112 | $0.9126 | $1.03 | +0.06% |
| Aug 11 | $0.8037 | $0.9127 | $1.04 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8037 | $0.9127 | $1.04 | +0.07% |
| Week 2 | $0.763 | $0.9133 | $1.09 | +0.15% |
| Week 3 | $0.7333 | $0.914 | $1.14 | +0.22% |
| Week 4 | $0.7092 | $0.9147 | $1.18 | +0.29% |
| Week 5 | $0.6887 | $0.9153 | $1.22 | +0.36% |
| Week 6 | $0.6708 | $0.916 | $1.25 | +0.44% |
| Week 7 | $0.6547 | $0.9167 | $1.28 | +0.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PMGC Holdings Inc. is a healthcare company focused on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
The lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Holdings Inc. trades under the ELAB symbol and has a current price of $0.9493 with a market cap of $4.31M, ranking 5036. This places it in the micro-cap space with a relatively small market footprint.
The price outlook summarized from the year-by-year forecast shows a path of modest gains at first, with higher potential later. The 2026 forecast shows an avg price of $0.9493 and a neutral stance, followed by gradual increases into subsequent years with notable bullish years starting near 2029 and continuing through 2050. The long-run forecast points to meaningful upside, reflected in higher avg prices and positive ROIs in later years.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 3.5% below — buyers have tended to step in here.
The nearest ceiling, 52.4% above — a clean break opens room to run.
A major ceiling 1435.1% above — clearing it would confirm fresh momentum.
Key ELAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9236 | Sell | $0.932 | Sell |
| MA 10 | $0.9607 | Sell | $0.9636 | Sell |
| MA 20 | $1.04 | Sell | $1.05 | Sell |
| MA 50 | $1.32 | Sell | $1.83 | Sell |
| MA 100 | $2.41 | Sell | $16.52 | Sell |
| MA 200 | $36.71 | Sell | $1,171.84 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.88 | Neutral |
| Stoch RSI (14) | 70.11 | Neutral |
| CCI (20) | -93.51 | Neutral |
| Williams %R (14) | -82.08 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -14.54 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 17.92 | Buy |
| TRIX (15) | -1.52 | Sell |
| Awesome (5,34) | -0.23 | Sell |
| Ultimate (7,14,28) | 34.43 | Neutral |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.91 | Buy |
| ADX (14) | 29.42 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is mixed, with sentiment labeled NEUTRAL. The RSI14 is 40, suggesting neither overbought nor oversold conditions.
The near-term moving averages show the SMA50 at $1.34 and the SMA200 at $37.33, indicating a wide gap between short- and long-term trends. The stock sits above a support level of $0.88 and below a resistance level of $1.43, placing the price within a limited 30-day range from $0.6848 to $1.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.88 | $0.912 | $1.13 | 0% | Neutral | |
| $0.6427 | $0.8653 | $1.26 | -5% | Neutral | |
| $0.6108 | $0.8681 | $1.34 | -5% | Neutral | |
| $0.8236 | $1.23 | $1.98 | +34% | Bullish | |
| $0.8163 | $1.27 | $2.12 | +39% | Bullish | |
| $0.6695 | $1.08 | $1.87 | +18% | Neutral | |
| $0.7226 | $1.21 | $2.15 | +32% | Bullish | |
| $0.6357 | $1.10 | $2.01 | +21% | Bullish | |
| $0.5462 | $0.9769 | $1.83 | +7% | Neutral | |
| $0.6803 | $1.26 | $2.40 | +38% | Bullish | |
| $0.688 | $1.49 | $3.11 | +63% | Bullish | |
| $1.42 | $3.15 | $7.26 | +246% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.88 | $0.912 | $1.15 | +0.00% |
| September 2026 | $0.8052 | $0.9732 | $1.22 | +6.71% |
| October 2026 | $0.7524 | $0.9207 | $1.18 | -5.39% |
| November 2026 | $0.6888 | $0.8516 | $1.11 | -7.51% |
| December 2026 | $0.6847 | $0.8544 | $1.13 | +0.33% |
Click any year to see its month-by-month ELAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ELAB is projected to trade between $0.88 and $1.13, averaging $0.912 — a potential gain of 0% from today's $0.912. A consolidation phase looks the most probable path here.
PMGC Holdings Inc.'s 2027 outlook centres on $0.8653, within a $0.6427 to $1.26 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. Price action looks broadly range-bound.
By 2028, ELAB could reach as high as $1.34, with a base case around $0.8681 and support toward $0.6108 — roughly -5% from $0.912. A consolidation phase looks the most probable path here.
Expect ELAB to range from $0.8236 to $1.98 through 2029. The $1.23 average target implies a +34% move from current prices. That is up +41% on the projected 2028 average. Momentum favours further upside here.
The ELAB price prediction for 2030 points to an average of $1.27 (low $0.8163, high $2.12) — a potential gain of +39% on today's $0.912. Buyers look set to stay in control over this stretch.
In 2031, ELAB is projected to trade between $0.6695 and $1.87, averaging $1.08 — a potential gain of +18% from today's $0.912. That is -15% versus the projected 2030 average. Price action looks broadly range-bound.
PMGC Holdings Inc.'s 2032 outlook centres on $1.21, within a $0.7226 to $2.15 range. That is up +12% on the projected 2031 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ELAB could reach as high as $2.01, with a base case around $1.10 and support toward $0.6357 — roughly +21% from $0.912. Momentum favours further upside here.
Expect ELAB to range from $0.5462 to $1.83 through 2034. The $0.9769 average target implies a +7% move from current prices. That is -11% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The ELAB price prediction for 2035 points to an average of $1.26 (low $0.6803, high $2.40) — a potential gain of +38% on today's $0.912. Momentum favours further upside here.
In 2040, ELAB is projected to trade between $0.688 and $3.11, averaging $1.49 — a potential gain of +63% from today's $0.912. That is up +18% on the projected 2035 average. Buyers look set to stay in control over this stretch.
PMGC Holdings Inc.'s 2050 outlook centres on $3.15, within a $1.42 to $7.26 range. That is up +112% on the projected 2040 average. That marks a +246% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ELAB today (≈ 1,096.491228 ELAB) could be worth
$3,458.95
+$2,458.95 (+246%) by 2050 · US Dollar
Based on the average projected ELAB price of $3.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELABwould be worth at today's price.
$1,000 invested in ELAB on Jul 31, 2025 (≈ 5.681818 ELAB) would be worth
$5.18
-$994.82 (-99.5%) today · 0.01× · US Dollar
Based on a ELAB entry price of $176 vs. today's $0.912.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.9 | $1,013.33 | +1.3% |
| 1 month ago | $1.28 | $712.5 | -28.7% |
| 3 months ago | $2.51 | $363.35 | -63.7% |
| 6 months ago | $20.1 | $45.37 | -95.5% |
| 1 year ago | $176 | $5.18 | -99.5% |
| All time (2.7y) ago | $400,842.09 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELAB forecast.
Our base-case forecast reaches $1.80 around 2050.
Implied market cap at $1.80: $8.18M
The multi-year forecast outlines a trajectory of rising averages and expanding upside. In 2029, the avg price is forecast at $1.29 with a max of $2.10 and a bullish sentiment, followed by 2030 with an avg of $1.32 and a max of $2.23, still bullish and delivering an estimated 38.7% ROI. The forecast continues to show bullish momentum into 2040, with an avg of $1.55 and a max of $3.28 achieving a 63.1% ROI, and culminates in 2050 with an avg of $3.31 and a max of $7.61, reflecting a 248.6% ROI.
Overall, the path suggests potential upside over the long term, but these are estimates and not guarantees. Market conditions, company developments, and broader industry factors can all influence actual results.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg price of $1.32 with a max of $2.23 and a projected ROI of 38.7%, with a bullish sentiment.
Forecasts show a mix of neutral and bullish periods. The 2026 year is neutral with an avg of $0.9493 and the 2029–2050 period turns bullish, with higher avg prices and notable ROIs such as 38.7% in 2030 and 248.6% in 2050.
Yes. The max forecasts include $2.23 in 2030, $2.29 in 2032, and $2.56 in 2035, with higher tops beyond that—$3.28 in 2040 and $7.61 in 2050.
The 30-day range is $0.6848 to $1.32, RSI14 is 40, SMA50 is $1.34, SMA200 is $37.33, with support at $0.88 and resistance at $1.43, and sentiment is NEUTRAL.
PMGC Holdings Inc. Community Discussion
0Share your PMGC Holdings Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.